MedPath

The Impact of the Timing of Trigger on IVF Success

Not Applicable
Terminated
Conditions
Infertility
Embryonic Development
Fertilization in Vitro
Registration Number
NCT02990949
Lead Sponsor
Colorado Center for Reproductive Medicine
Brief Summary

The aim of this study is to examine the length of ovarian stimulation with the timing of trigger in an IVF cycle and its potential to impact patient outcomes.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
29
Inclusion Criteria
  • Planning to move forward with an IVF cycle
  • Have met the requirements of being a patient at CCRM Colorado
  • AMA: 39-44 years old And/or
  • DOR: AMH < 1 & FSH >10 (age independent)
Exclusion Criteria
  • Contraindication for pregnancy
  • Have not fulfilled requirements for IVF cycle
  • Single gene couple or chromosomal rearrangement
  • Severe male factor or testicular surgical sperm removal (need sufficient sperm for ICSI)
  • One ovary
  • Uterine anomalies
  • Stage III or IV endometriosis
  • Explained recurrent miscarriage
  • PCO or PCOS
  • Using donor oocyte or gestational carrier

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Euploid Embryos: the percentage of euploid embryos produced as analyzed by comprehensive chromosomal screening, of total embryos tested4 weeks after egg retrieval
Secondary Outcome Measures
NameTimeMethod
Egg maturation: the proportion of mature eggs of total number of eggs retrieved1 week after egg retrieval
Live birth outcomes: the incidence of pregnancy resulting in live birth following embryo transfer of embryos produced by this IVF cycle9 months after frozen embryo transfer

Trial Locations

Locations (1)

Colorado Center for Reproductive Medicine

🇺🇸

Lone Tree, Colorado, United States

Colorado Center for Reproductive Medicine
🇺🇸Lone Tree, Colorado, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.